CRO (Global Contract Research Organization) Market Set for Explosive Growth, to Reach USD 59.42 Billion in 2020, Growing at 9.80% CAGR - Market Research Store
January 12, 2016 11:21 ET
|
Market Research Store
Deerfield Beach, FL, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “Contract Research Organization (CRO) Industry for Early-Stage Development Services and...
INC Research Named Best Contract Research Organization at 11th Annual Scrip Awards
December 03, 2015 12:25 ET
|
Syneos Health, Inc.
RALEIGH, N.C., Dec. 03, 2015 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (INC Research) (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced the...
INC Research Announces Pricing of Secondary Offering and Repurchase of Common Stock
December 02, 2015 08:59 ET
|
Syneos Health, Inc.
RALEIGH, N.C., Dec. 02, 2015 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR) (the “Company”), a leading global Phase I to Phase IV contract research organization, today announced the...
INC Research Reports Third Quarter 2015 Results
October 29, 2015 06:02 ET
|
Syneos Health, Inc.
HighlightsBook-to-bill of 1.4x for the third quarter of 2015 and 1.3x for each of the nine and twelve month periods ended September 30, 2015.Net new business awards of $327.7 million and $879.1...
ISR Projects a 7.4% Compound Annual Growth Rate for the CRO Market Through 2019
February 11, 2015 11:06 ET
|
Industry Standard Research
CARY, NC--(Marketwired - February 11, 2015) - Industry Standard Research (ISR Reports) has announced the availability of a new report titled "2015 Edition of the CRO Market Size Projections:...
Factory-CRO Announces "International Clinical Trial Rescue" Program for Medical Devices
July 15, 2014 10:30 ET
|
Factory CRO
BILTHOVEN, THE NETHERLANDS--(Marketwired - Jul 15, 2014) - Factory CRO today announced a new early-detection program designed to help medical device companies correct poorly designed clinical...
PCI Synthesis Announces Successful FDA Inspection and Pre-Approval of Two Products
September 18, 2013 09:17 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Sep 18, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a custom chemical manufacturer of new chemical entities (NCE), generic active pharmaceutical ingredients...
PCI Announces 2013 Trends and Predictions
November 12, 2012 08:13 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Nov 12, 2012) - PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Sponsors MassBio's Massachusetts CRO/CMO Symposium
February 15, 2012 14:16 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Feb 15, 2012) - PCI (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients...